Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity
- PMID: 34307989
- PMCID: PMC8258454
- DOI: 10.1016/j.ekir.2021.04.016
Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity
Erratum in
-
Corrigendum to "Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity" Kidney Int. Rep. 2021;6:1949-1960.Kidney Int Rep. 2021 Aug 31;6(10):2735. doi: 10.1016/j.ekir.2021.08.023. eCollection 2021 Oct. Kidney Int Rep. 2021. PMID: 34622116 Free PMC article.
Abstract
Introduction: Lupus nephritis (LN) confers a poor prognosis, mainly from lack of effective laboratory tests to diagnose and to evaluate therapies. We have previously shown that a set of 6 urinary biomarkers (NGAL, KIM-1, MCP-1, adiponectin, hemopexin, and ceruloplasmin) are highly sensitive and specific to identify adult and pediatric patients with active LN using renal biopsy as reference standard. Using these combinatorial urinary biomarkers, the Renal Activity Score for Lupus (RAIL) score was established, with biomarkers measured by enzyme-linked immunosorbent assay (ELISA). To enhance clinical utility of the biomarkers and RAIL, we tested the performance of RAIL with biomarkers measured by ELISA to that of biomarkers measured by the bead multiplex method, hypothesizing that the multiplex bead method would be comparable.
Methods: Spot urine samples (n = 341) of 46 patients aged 20 to 73 years with or without LN were used. Samples were assayed both by ELISA and multiplex using LUMINEX. RAIL scores and biomarker quantities were assessed for agreement with intraassay correlation coefficients and compared using Bland-Altman and regression.
Results: Biomarker measurement by LUMINEX was successful for NGAL, KIM-1, MCP-1, and adiponectin, but not for ceruloplasmin and hemopexin. There was good agreement of the RAIL obtained from these 4 biomarkers, irrespective of assay method (intraclass correlation coefficient [ICC] = 0.78, 95% confidence interval [CI] = 0.78-0.82). The RAIL scores from 4 biomarkers further correlated with those when considering all 6 biomarkers (ICC = 0.97, 95% CI = 0.96-0.98).
Conclusion: The LUMINEX platform allows for the convenient and simultaneous measurement of 4 RAIL biomarkers. RAIL scores considering only these 4 biomarkers may be sufficient to accurately capture LN activity.
Keywords: ELISA; RAIL; SLE; lupus; multiplex; nephritis.
© 2021 International Society of Nephrology. Published by Elsevier Inc.
Figures







Similar articles
-
Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).Pediatr Rheumatol Online J. 2017 Oct 13;15(1):74. doi: 10.1186/s12969-017-0202-0. Pediatr Rheumatol Online J. 2017. PMID: 29029629 Free PMC article.
-
Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus.Lupus Sci Med. 2022 May;9(1):e000631. doi: 10.1136/lupus-2021-000631. Lupus Sci Med. 2022. PMID: 35568436 Free PMC article.
-
Stability of novel urinary biomarkers used for lupus nephritis.Front Pediatr. 2022 Jul 29;10:974049. doi: 10.3389/fped.2022.974049. eCollection 2022. Front Pediatr. 2022. PMID: 35967565 Free PMC article.
-
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13. Am J Nephrol. 2021. PMID: 34515043
-
Proteomic profiling of urine: implications for lupus nephritis.Expert Rev Proteomics. 2019 Apr;16(4):303-313. doi: 10.1080/14789450.2019.1592681. Epub 2019 Mar 18. Expert Rev Proteomics. 2019. PMID: 30855196 Free PMC article. Review.
Cited by
-
Advances in proteomic profiling of pediatric kidney diseases.Pediatr Nephrol. 2022 Oct;37(10):2255-2265. doi: 10.1007/s00467-022-05497-2. Epub 2022 Feb 26. Pediatr Nephrol. 2022. PMID: 35220505 Free PMC article. Review.
-
Development and Validation of Multiplex Assays for Lupus Nephritis Activity Biomarkers.Kidney Int Rep. 2025 Apr 21;10(7):2255-2264. doi: 10.1016/j.ekir.2025.04.013. eCollection 2025 Jul. Kidney Int Rep. 2025. PMID: 40677325 Free PMC article.
-
The Utility of Novel Kidney Injury Biomarkers in Early Detection of CSA-AKI.Int J Mol Sci. 2022 Dec 14;23(24):15864. doi: 10.3390/ijms232415864. Int J Mol Sci. 2022. PMID: 36555506 Free PMC article.
-
Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis.Lupus Sci Med. 2023 Jan;10(1):e000747. doi: 10.1136/lupus-2022-000747. Lupus Sci Med. 2023. PMID: 36717181 Free PMC article.
-
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention.Curr Rheumatol Rep. 2023 Oct;25(10):183-191. doi: 10.1007/s11926-023-01109-6. Epub 2023 Jul 15. Curr Rheumatol Rep. 2023. PMID: 37452914 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous